News
Employer Costs · GLP-1 Drugs · Health Insurance · Healthcare Inflation
US employers face an unprecedented surge in health insurance costs, with projections indicating a nearly 10% increase for 2026, marking the steepest jump in over 15 years.
This follows years of continuous rises, pushing the average family plan to approximately $25,500 annually. The escalating expenses are attributed to several factors, including soaring hospital bills, broader utilization of medical services, and the introduction of costly new drugs, notably GLP-1 treatments for weight loss and diabetes.
Additionally, a rise in cancer and chronic conditions among working-age Americans is straining coverage. Companies are reacting with alarm, with many considering shifting costs to employees through higher payroll deductions or deductibles, while others explore plan redesigns to restrict access to certain providers.
A significant 60% of large employers are contemplating switching insurers or pharmacy-benefit managers. Examples like Kall Morris Inc.
experiencing a 20% hike and Mutual of Omaha dropping GLP-1 weight-loss coverage highlight the severe financial strain and difficult decisions businesses are making to manage these "unsustainable" costs.
